Literature DB >> 33572549

The Stem Cell Revolution Revealing Protozoan Parasites' Secrets and Paving the Way towards Vaccine Development.

Alena Pance1.   

Abstract

Protozoan infections are leading causes of morbidity and mortality in humans and some of the most important neglected diseases in the world. Despite relentless efforts devoted to vaccine and drug development, adequate tools to treat and prevent most of these diseases are still lacking. One of the greatest hurdles is the lack of understanding of host-parasite interactions. This gap in our knowledge comes from the fact that these parasites have complex life cycles, during which they infect a variety of specific cell types that are difficult to access or model in vitro. Even in those cases when host cells are readily available, these are generally terminally differentiated and difficult or impossible to manipulate genetically, which prevents assessing the role of human factors in these diseases. The advent of stem cell technology has opened exciting new possibilities to advance our knowledge in this field. The capacity to culture Embryonic Stem Cells, derive Induced Pluripotent Stem Cells from people and the development of protocols for differentiation into an ever-increasing variety of cell types and organoids, together with advances in genome editing, represent a huge resource to finally crack the mysteries protozoan parasites hold and unveil novel targets for prevention and treatment.

Entities:  

Keywords:  induced pluripotent stem cells; organoids; protozoan parasites; stem cells; treatments; vaccines

Year:  2021        PMID: 33572549      PMCID: PMC7911700          DOI: 10.3390/vaccines9020105

Source DB:  PubMed          Journal:  Vaccines (Basel)        ISSN: 2076-393X


  88 in total

Review 1.  In vitro cultivation of cryptosporidium species.

Authors:  Michael J Arrowood
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

Review 2.  Organoids as an in vitro model of human development and disease.

Authors:  Aliya Fatehullah; Si Hui Tan; Nick Barker
Journal:  Nat Cell Biol       Date:  2016-03       Impact factor: 28.824

3.  Generating human intestinal tissue from pluripotent stem cells in vitro.

Authors:  Kyle W McCracken; Jonathan C Howell; James M Wells; Jason R Spence
Journal:  Nat Protoc       Date:  2011-11-10       Impact factor: 13.491

Review 4.  Lytic Cycle of Toxoplasma gondii: 15 Years Later.

Authors:  Ira J Blader; Bradley I Coleman; Chun-Ti Chen; Marc-Jan Gubbels
Journal:  Annu Rev Microbiol       Date:  2015-08-28       Impact factor: 15.500

Review 5.  Possibilities and challenges for developing a successful vaccine for leishmaniasis.

Authors:  Saumya Srivastava; Prem Shankar; Jyotsna Mishra; Sarman Singh
Journal:  Parasit Vectors       Date:  2016-05-12       Impact factor: 3.876

6.  Novel 2D and 3D Assays to Determine the Activity of Anti-Leishmanial Drugs.

Authors:  Alec O'Keeffe; Christine Hale; James A Cotton; Vanessa Yardley; Kapish Gupta; Abhishek Ananthanarayanan; Sudaxshina Murdan; Simon L Croft
Journal:  Microorganisms       Date:  2020-06-01

7.  A Novel Chemically Differentiated Mouse Embryonic Stem Cell-Based Model to Study Liver Stages of Plasmodium berghei.

Authors:  Jaishree Tripathi; Charis-Patricia Segeritz; Gareth Griffiths; Wendy Bushell; Ludovic Vallier; William C Skarnes; Maria M Mota; Oliver Billker
Journal:  Stem Cell Reports       Date:  2020-05-21       Impact factor: 7.765

8.  Modelling Cryptosporidium infection in human small intestinal and lung organoids.

Authors:  Inha Heo; Devanjali Dutta; Deborah A Schaefer; Nino Iakobachvili; Benedetta Artegiani; Norman Sachs; Kim E Boonekamp; Gregory Bowden; Antoni P A Hendrickx; Robert J L Willems; Peter J Peters; Michael W Riggs; Roberta O'Connor; Hans Clevers
Journal:  Nat Microbiol       Date:  2018-06-25       Impact factor: 17.745

9.  Toxoplasmosis--a global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries.

Authors:  Jaroslav Flegr; Joseph Prandota; Michaela Sovičková; Zafar H Israili
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

Review 10.  Physiological, pharmacological and toxicological considerations of drug-induced structural cardiac injury.

Authors:  M J Cross; B R Berridge; P J M Clements; L Cove-Smith; T L Force; P Hoffmann; M Holbrook; A R Lyon; H R Mellor; A A Norris; M Pirmohamed; J D Tugwood; J E Sidaway; B K Park
Journal:  Br J Pharmacol       Date:  2015-01-12       Impact factor: 8.739

View more
  1 in total

Review 1.  In Vitro Assessment of Anticoccidials: Methods and Molecules.

Authors:  Martina Felici; Benedetta Tugnoli; Andrea Piva; Ester Grilli
Journal:  Animals (Basel)       Date:  2021-06-30       Impact factor: 2.752

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.